STOCK TITAN

24,965-share Rule 144 sale notice for Neurocrine (NASDAQ: NBIX)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Notification of proposed sale of Common Stock under Rule 144. The filing lists 24,965 shares of Common Stock to be sold on 06/02/2026 described as resulting from an Exercise of Stock Options. The report also lists 9,879 Restricted and Performance Stock Units (02/08/2021) and 2,093 previously exercised stock options (08/04/2020).

The broker is listed as Morgan Stanley Smith Barney LLC and the execution venue is shown as NASDAQ.

Positive

  • None.

Negative

  • None.

Insights

Form 144 notice lists a sale of 24,965 Common shares tied to option exercise.

The filing records a proposed sale under Rule 144 on 06/02/2026 by a broker-dealer, with the principal method listed as Exercise of Stock Options. The entry also enumerates related equity items: 9,879 RSUs and 2,093 previously exercised options, which appear as provenance for saleable shares.

Timing and cash‑flow treatment are those typical of Rule 144 notices; subsequent Form 4 or sale confirmations will show actual transaction settlement and proceeds.

Shares proposed for sale 24,965 shares Exercise of Stock Options on 06/02/2026
Restricted and Performance Stock Units 9,879 units Grant date 02/08/2021
Previously exercised stock options 2,093 shares Exercise date 08/04/2020
Execution venue NASDAQ Listed for sale on 06/02/2026
Broker-dealer Morgan Stanley Smith Barney LLC Intermediary listed on Form 144
Exercise of Stock Options financial
"Securities To Be Sold 06/02/2026 Exercise of Stock Options"
Restricted and Performance Stock Units financial
"Common 02/08/2021 Restricted and Performance Stock Units"
Previously Exercised Stock Options financial
"Common 08/04/2020 Previously Exercised Stock Options"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does NBIX's Form 144 report show?

It reports a proposed sale of 24,965 shares of Common Stock on 06/02/2026. The filing lists these shares as from an Exercise of Stock Options and names the executing broker as Morgan Stanley Smith Barney LLC.

Are there other equity items listed in the NBIX filing?

Yes. The filing lists 9,879 Restricted and Performance Stock Units dated 02/08/2021 and 2,093 previously exercised stock options dated 08/04/2020. These items are shown alongside the sale entry.

Does the Form 144 confirm the sale is completed?

No. Form 144 is a notice of intent to sell under Rule 144, not a settlement confirmation. Completion and proceeds will be shown in subsequent transaction records or broker confirmations when available.

Which broker and exchange are identified for the planned sale?

The filing names Morgan Stanley Smith Barney LLC as the broker-dealer and indicates NASDAQ as the execution venue for the reported securities to be sold on 06/02/2026.